{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:38:03Z","timestamp":1793374683432,"version":"4.5.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Tanoto Foundation Professorship in Cardiovascular Medicine","id":[{"id":"https:\/\/ror.org\/00d72ef81","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health, Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-STaR21jun-0003"],"award-info":[{"award-number":["MOH-STaR21jun-0003"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CArdiovascular DiseasE National Collaborative Enterprise"},{"name":"National Clinical Translational Program","award":["MOH-001277-01"],"award-info":[{"award-number":["MOH-001277-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,30]]},"DOI":"10.1093\/ehjci\/jeag229","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:31:31Z","timestamp":1788075091000},"page":"1953-1954","source":"Crossref","is-referenced-by-count":0,"title":["The molecular footprint of thrombosis: what does myocardial platelet imaging after STEMI tell us?"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-1783","authenticated-orcid":false,"given":"Heerajnarain","family":"Bulluck","sequence":"first","affiliation":[{"name":"Department of Cardiology, Leeds General Infirmary , Leeds ,","place":["UK"]},{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds ,","place":["UK"]},{"name":"Department of Cardiology, Beacon Hospital , Dublin ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-4956","authenticated-orcid":false,"given":"Derek J","family":"Hausenloy","sequence":"additional","affiliation":[{"name":"National Heart Centre Singapore Department of Cardiology, ,","place":["Singapore"]},{"name":"Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore ,","place":["Singapore"]},{"name":"Yong Loo Lin School of Medicine, National University Singapore ,","place":["Singapore"]},{"name":"The Hatter Cardiovascular Institute, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"2026103011075583900_jeag229-B1","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"2026103011075583900_jeag229-B2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial","volume":"394","author":"Hausenloy","year":"2019","journal-title":"Lancet"},{"key":"2026103011075583900_jeag229-B3","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/ehjci\/jeag225","article-title":"Platelet activation and thrombosis in microvascular obstruction","volume":"27","author":"Balmforth","year":"2026","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026103011075583900_jeag229-B4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003900","article-title":"Quantifying the area-at-risk in reperfused STEMI patients using hybrid cardiac PET-MR imaging","volume":"9","author":"Bulluck","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026103011075583900_jeag229-B5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcmg.2017.01.008","article-title":"Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials","volume":"10","author":"Bulluck","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026103011075583900_jeag229-B6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004940","article-title":"Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling","volume":"9","author":"Bulluck","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026103011075583900_jeag229-B7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jacc.2024.03.408","article-title":"Clinical outcomes associated with various microvascular injury patterns identified by CMR after STEMI","volume":"83","author":"Lechner","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026103011075583900_jeag229-B8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jacc.2020.01.041","article-title":"Low-dose alteplase during primary percutaneous coronary intervention according to ischemic time","volume":"75","author":"McCartney","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026103011075583900_jeag229-B9","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1093\/eurheartj\/ehae587","article-title":"Glycoprotein IIb\/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial","volume":"45","author":"Eitel","year":"2024","journal-title":"Eur Heart J"},{"key":"2026103011075583900_jeag229-B10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCULATIONAHA.124.068938","article-title":"Effect of cangrelor on infarct size in ST-segment-elevation myocardial infarction treated by primary percutaneous coronary intervention: a randomized controlled trial (the PITRI trial)","volume":"150","author":"Bulluck","year":"2024","journal-title":"Circulation"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag229\/70822555\/jeag229.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/11\/1953\/70822555\/jeag229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/11\/1953\/70822555\/jeag229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:08:03Z","timestamp":1793372883000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/11\/1953\/8772115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,8,30]]},"published-print":{"date-parts":[[2026,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag229","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,8,30]]}}}